Search | IOVS | ARVO Journals

Showing 1 – 20 of 40

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2021

Comparison of real-life treatment of naïve patients with ranibizumab over 24 months for neovascular AMD, diabetic macular edema, retinal vein occlusion and myopic CNV – results of the current interim analysis of the PACIFIC study

Ramin Khoramnia; Christos Haritoglou; Kristina Markova; Matthias Iwersen; Ulrike Michel; Salvatore Grisanti; Thomas Hammer; Jens Schrecker; Christoph Winkler von Mohrenfels; Focke Ziemssen

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):287. doi:

ARVO Annual Meeting Abstract June 2020

Real world evidence of retinal vein occlusion (RVO) patient treatment with ranibizumab in Germany based on the 24 months interim results of the non-interventional, observational PACIFIC study

Katrin Lorenz; Christos Haritoglou; Kristina Markova; Berenice Rösler; Matthias Iwersen; Ulrike Michel; Bianca Apitzsch; Hüsnü Berk; Christian Karl Brinkmann; Ramin Khoramnia; Martin Scheffler; Jens Schrecker; Gregor Schwert; Focke Ziemssen

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1310. doi:

ARVO Annual Meeting Abstract July 2019

Observation of ranibizumab treatment in real-life conditions – an interim analysis of the myopic choroidal neovascularization (mCNV) population within the observational, non-interventional PACIFIC study

Kristina Markova; Christos Haritoglou; Matthias Iwersen; Ulrike Michel; Martina Junge; Peter Geuking; Katrin Lorenz; Thomas Ach; Ramin Khoramnia; Andreas Schmidt; Judith Becker; Erik Beeke; Mathias Müller-Holz; Daniel Barthelmes; Focke Ziemssen

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4320. doi:

ARVO Annual Meeting Abstract July 2018

The vitreoretinal interface in eyes with macular hole or macular pucker – how often do we find a vitreopapillary adhesion? An SD-OCT-based morphological study

Julian Klaas; Christiane Frank; Melanie Weschta; Nikolaus Feucht; Christos Haritoglou; Chris Patrick Lohmann; Mathias Maier

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5274. doi:

ARVO Annual Meeting Abstract July 2018

Interim results of the German diabetic macula edema (DME) population within the PACIFIC study

Kristina Markova; Christos Haritoglou; Matthias Iwersen; Ulrike Michel; Florian Diwischek; Matthias Grüb; Focke Ziemssen

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3612. doi:

ARVO Annual Meeting Abstract June 2017

Biomechanical modeling of macular hole formation and development

Anissa Frank; Alexander Jung; Manfred Staat; Michael Engelbert; Alexey Dashevsky; Christos Haritoglou; Mathias M Maier; Konstantin E Kotliar

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3701. doi:

Multidisciplinary Ophthalmic Imaging October 2015

Combined 60° Wide-Field Choroidal Thickness Maps and High-Definition En Face Vasculature Visualization Using Swept-Source Megahertz OCT at 1050 nm

PDF

Kathrin J. Mohler; Wolfgang Draxinger; Thomas Klein; Jan Philip Kolb; Wolfgang Wieser; Christos Haritoglou; Anselm Kampik; James G. Fujimoto; Aljoscha S. Neubauer; Robert Huber; Armin Wolf
TAGS: choroid, diagnostic imaging, face, maps, vasculature, summation
Invest. Ophthalmol. Vis. Sci.. 2015; 56(11):6284-6293. doi: https://doi.org/10.1167/iovs.15-16670

Includes: Supplemental Content

ARVO Annual Meeting Abstract April 2014

Wide Field MHz OCT imaging of the vitreoretinal interface

Karsten Ulrich Kortuem; Jan Philip Kolb; Thomas Klein; Kathrin Mohler; Anselm Kampik; Aljoscha S Neubauer; Wolfgang Wieser; Robert Huber; Christos Haritoglou

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1619. doi:

ARVO Annual Meeting Abstract April 2014

Combination Of Navigated Laser Photocoagulation And Intravitreal Ranibizumab In The Treatment Of Diabetic Macular Edema: Two-year results

Marcus Kernt; Raffael Liegl; Christos Haritoglou; Aljoscha S Neubauer; Anselm Kampik

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1703. doi:

ARVO Annual Meeting Abstract June 2013

EGF-Receptor inhibitor Gefitinib as a potential pharmacological prophylaxis for posterior capsule opacification

Peter Laubichler; Christian Wertheimer; Raffael Liegl; Marcus Kernt; Armin Wolf; Christos Haritoglou; Anselm Kampik; Kirsten Eibl-Lindner

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):2956. doi:

ARVO Annual Meeting Abstract June 2013

Combination of Ranibizumab and Navigated Retinal Photocoagulation in Diabetic Macular Edema, compared to Ranibizumab Mono-Therapy: Twelve Month Results

Sarah Cserhati; Raffael Liegl; Michael Ulbig; Christos Haritoglou; Anselm Kampik; Aljoscha Neubauer; Marcus Kernt

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):1240. doi:

Retina June 2012

Nanoscale Topographic and Biomechanical Studies of the Human Internal Limiting Membrane

PDF

Paul B. Henrich; Christophe A. Monnier; Willi Halfter; Christos Haritoglou; Rupert W. Strauss; Roderick Y. H. Lim; Marko Loparic
TAGS: fovea centralis, tissue membrane, retina, eye, vitreous body, language morphology, morphology
Invest. Ophthalmol. Vis. Sci.. 2012; 53(6):2561-2570. doi: https://doi.org/10.1167/iovs.11-8502

ARVO Annual Meeting Abstract March 2012

Idebenone Prevents Retinal Pigmentepithelium (RPE) Cells from Oxidative Stress and Senescence

Nicole Arend; Susanna Koenig; Peter Laubichler; Armin Wolf; Christos Haritoglou; Michael W. Ulbig; Anselm Kampik; Marcus Kernt

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):6887. doi:

ARVO Annual Meeting Abstract March 2012

Inhibiton Of Human Lens Epithelial Cell Contraction By Alkylphosphocholines For PCO Prophylaxis And Downregulation Of The PI3K Pathway

Raffael Liegl; Marcus Kernt; Armin Wolf; Daniel Kook; Christos Haritoglou; Anselm Kampik; Kirsten H. Eibl-Lindner

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):6909. doi:

ARVO Annual Meeting Abstract March 2012

Retinal Pigmentepithelium (RPE) Alterations Correspond to Retinal Nerve Fiber Layer (RNFL) Degeneration in Glaucoma

Florian Seidensticker; Aljoscha S. Neubauer; Thomas Mann; Irene Huebert; Christos Haritoglou; Christoph Hirneiss; Marcus Kernt

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):719. doi:

ARVO Annual Meeting Abstract March 2012

A Comparison of Intravitreal Bevacizumab Up-load Followed by a dexamethasone-implant versus dexamethasone-implant Mono Therapy for Retinal Vein Occlusion with Macular Edema

Wolfgang J. Mayer; Armin Wolf; Lukas Reznicek; Daniel Kook; Anselm Kampik; Michael Ulbig; Christos Haritoglou

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):915. doi:

ARVO Annual Meeting Abstract March 2012

Evaluation of the Biocompatibility of a New Cyanine Dye for Lens Capsule Staining

Peter Laubichler; Marcus Kernt; Ana Varja; Anselm Kampik; Heinz Langhals; Christos Haritoglou

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):1052. doi:

ARVO Annual Meeting Abstract March 2012

EGF-Receptor Inhibitor Erlotinib As A Potential Pharmacological Prophylaxis For Posterior Capsule Opacification

Christian M. Wertheimer; Raffael Liegl; Marcus Kernt; Armin Wolf; Denitsa Docheva; Christos Haritoglou; Anselm Kampik; Kirsten H. Eibl

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):3047. doi:

ARVO Annual Meeting Abstract March 2012

Conjunctival Bacterial Flora And Antibiotic Resistance Patterns After Pre-operative Application Of Topical Levofloxacin 0.3%

Herminia Mino de Kaspar; Larissa E. Hoffmann; Lisa He; Bing Li; Martin M. Nentwich; Christos Haritoglou; Daniel Kook; Martin Grueterich; Anselm Kampik

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):6681. doi:

ARVO Annual Meeting Abstract March 2012

Anti-Proliferative Actions of the mTOR Inhibitor Temsirolimus in Primary Human Retinal Pigmentepithelium (RPE) and Vascular Endothelial Cells

Susanna Koenig; Raffael G. Liegl; Aljoscha S. Neubauer; Lukas Reznicek; Christos Haritoglou; Michael W. Ulbig; Anselm Kampik; Marcus Kernt

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2242. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Comparison of real-life treatment of naïve patients with ranibizumab over 24 months for neovascular AMD, diabetic macular edema, retinal vein occlusion and myopic CNV – results of the current interim analysis of the PACIFIC study

Real world evidence of retinal vein occlusion (RVO) patient treatment with ranibizumab in Germany based on the 24 months interim results of the non-interventional, observational PACIFIC study

Observation of ranibizumab treatment in real-life conditions – an interim analysis of the myopic choroidal neovascularization (mCNV) population within the observational, non-interventional PACIFIC study

The vitreoretinal interface in eyes with macular hole or macular pucker – how often do we find a vitreopapillary adhesion? An SD-OCT-based morphological study

Interim results of the German diabetic macula edema (DME) population within the PACIFIC study

Biomechanical modeling of macular hole formation and development

Combined 60° Wide-Field Choroidal Thickness Maps and High-Definition En Face Vasculature Visualization Using Swept-Source Megahertz OCT at 1050 nm

Wide Field MHz OCT imaging of the vitreoretinal interface

Combination Of Navigated Laser Photocoagulation And Intravitreal Ranibizumab In The Treatment Of Diabetic Macular Edema: Two-year results

EGF-Receptor inhibitor Gefitinib as a potential pharmacological prophylaxis for posterior capsule opacification

Combination of Ranibizumab and Navigated Retinal Photocoagulation in Diabetic Macular Edema, compared to Ranibizumab Mono-Therapy: Twelve Month Results

Nanoscale Topographic and Biomechanical Studies of the Human Internal Limiting Membrane

Idebenone Prevents Retinal Pigmentepithelium (RPE) Cells from Oxidative Stress and Senescence

Inhibiton Of Human Lens Epithelial Cell Contraction By Alkylphosphocholines For PCO Prophylaxis And Downregulation Of The PI3K Pathway

Retinal Pigmentepithelium (RPE) Alterations Correspond to Retinal Nerve Fiber Layer (RNFL) Degeneration in Glaucoma

A Comparison of Intravitreal Bevacizumab Up-load Followed by a dexamethasone-implant versus dexamethasone-implant Mono Therapy for Retinal Vein Occlusion with Macular Edema

Evaluation of the Biocompatibility of a New Cyanine Dye for Lens Capsule Staining

EGF-Receptor Inhibitor Erlotinib As A Potential Pharmacological Prophylaxis For Posterior Capsule Opacification

Conjunctival Bacterial Flora And Antibiotic Resistance Patterns After Pre-operative Application Of Topical Levofloxacin 0.3%

Anti-Proliferative Actions of the mTOR Inhibitor Temsirolimus in Primary Human Retinal Pigmentepithelium (RPE) and Vascular Endothelial Cells

To View More...

You must be signed into an individual account to use this feature.